Long-term efficacy and safety of sirolimus therapy in patients with lymphangioleiomyomatosis

Long-term efficacy and safety of sirolimus therapy in patients with lymphangioleiomyomatosis

Abstract Background Sirolimus has been confirmed to be effective for lymphangioleiomyomatosis (LAM), a rare multisystem neoplastic disease in women. The long-term effects of sirolimus treatment for LAM, however, are largely unknown. We aimed to analyze the long-term efficacy and safety of sirolimus...

Full description

Bibliographic Details
Main Authors: Siqi Hu, Xiuxiu Wu, Wenshuai Xu, Xinlun Tian, Yanli Yang, Shao-Ting Wang, Song Liu, Xingxiang Xu, Kai-Feng Xu
Format: Article
Language:English
Published: BMC 2019-08-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Lymphangioleiomyomatosis
Sirolimus
Pulmonary function
Online Access:http://link.springer.com/article/10.1186/s13023-019-1178-2

Internet

http://link.springer.com/article/10.1186/s13023-019-1178-2

Similar Items